UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ein weiterer Eingriff in unsere Freiberuflichkeit – das Bundesgesundheitsministerium ignoriert weiter hartnäckig die Selbstverwaltung

Urologie (Heidelberg, Germany), 2023-08, Vol.62 (8), p.784-789

Goebell, Peter J.

2023

Volltextzugriff (PDF)

Individualisierte Präzisionsmedizin

Urologie (Heidelberg, Germany), 2023-09, Vol.62 (9), p.879-888

2023

Volltextzugriff (PDF)

Another encroachment on our liberal profession-The German Federal Ministry of Health continues to stubbornly ignore the self-government

Urologie (Heidelberg, Germany), 2023-07

Goebell, Peter J

2023

Volltextzugriff (PDF)

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis

PloS one, 2017-06, Vol.12 (6), p.e0179602

2017

Volltextzugriff (PDF)

Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium

Urologic oncology, 2010-07, Vol.28 (4), p.409-428

2010

Volltextzugriff (PDF)

The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents

Journal of clinical oncology, 2021-06, Vol.39 (18), p.JCO2003088-1994

2021

Volltextzugriff (PDF)

Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study

British journal of nutrition, 2023-08, Vol.130 (3), p.495-502

2023

Volltextzugriff (PDF)

Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma

Urologic oncology, 2023-09, Vol.41 (9), p.392.e1-392.e9

2023

Volltextzugriff (PDF)

Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia

Future oncology (London, England), 2024-05, Vol.20 (14), p.903-918

2024

Volltextzugriff (PDF)

Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma

Journal of clinical medicine, 2019-05, Vol.8 (5), p.743

2019

Volltextzugriff (PDF)

Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction

Urologia internationalis, 2022-10, Vol.106 (10), p.1041-1049

2022

Volltextzugriff (PDF)

Follow-up in non–muscle-invasive bladder cancer—International Bladder Cancer Network recommendations

Urologic oncology, 2016-10, Vol.34 (10), p.460-468

2016

Volltextzugriff (PDF)

First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial

International journal of cancer, 2021-02, Vol.148 (4), p.950-960

2021

Volltextzugriff (PDF)

Statistical consideration for clinical biomarker research in bladder cancer

Urologic oncology, 2010-07, Vol.28 (4), p.389-400

2010

Volltextzugriff (PDF)

Another encroachment on our liberal profession-The German Federal Ministry of Health continues to stubbornly ignore the self-government

Urologie (Heidelberg, Germany), 2023-08, Vol.62 (8), p.784-789

Goebell, Peter J

2023

Volltextzugriff (PDF)

Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review

Urologia internationalis, 2024-06, Vol.108 (3), p.198-13

2024

Volltextzugriff (PDF)

Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients

European urology oncology, 2018-06, Vol.1 (2), p.91-100

2018

Volltextzugriff (PDF)

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape

Cancers, 2022-11, Vol.14 (22), p.5486

2022

Volltextzugriff (PDF)

Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma

Future oncology (London, England), 2020-10, Vol.16 (29), p.2307-2328

2020

Volltextzugriff (PDF)

Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial

International journal of cancer, 2021-04, Vol.148 (7), p.1685-1694

2021

Volltextzugriff (PDF)

Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC‐Registry

International journal of cancer, 2020-03, Vol.146 (5), p.1307-1315

2020

Volltextzugriff (PDF)

Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry

Clinical genitourinary cancer, 2017-04, Vol.15 (2), p.e209-e215

2017

Volltextzugriff (PDF)

68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients

Annals of nuclear medicine, 2019-10, Vol.33 (10), p.766-775

2019

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Englisch
(193)
Deutsch
(20)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(117)
Humans
(94)
Oncology
(65)
Urology & Nephrology
(59)
Male
(56)
Aged
(42)
Middle Aged
(42)
Female
(39)
Bladder Cancer
(36)
Biological And Medical Sciences
(35)
Urology
(31)
Adult
(29)
Medical Sciences
(29)
Prognosis
(28)
Aged, 80 And Over
(25)
Urinary Bladder Neoplasms - Pathology
(19)
Treatment Outcome
(18)
Nephrology. Urinary Tract Diseases
(17)
Renal Cell Carcinoma
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ein weiterer Eingriff in unsere Freiberuflichkeit – das Bundesgesundheitsministerium ignoriert weiter hartnäckig die Selbstverwaltung

Individualisierte Präzisionsmedizin

Another encroachment on our liberal profession-The German Federal Ministry of Health continues to stubbornly ignore the self-government

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis

Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents

Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study

Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma

Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia

SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer

Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma

Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction

Follow-up in non–muscle-invasive bladder cancer—International Bladder Cancer Network recommendations

First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial

Statistical consideration for clinical biomarker research in bladder cancer

Another encroachment on our liberal profession-The German Federal Ministry of Health continues to stubbornly ignore the self-government

Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review

Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape

Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma

Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial

Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC‐Registry

Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry

68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients

Suchergebnisse filtern